Skip to main content

Table 2 Primary and secondary efficacy endpoints

From: Minimal-access video-assisted retroperitoneal and/or transperitoneal debridement (VARTD) in the management of infected walled-off pancreatic necrosis with deep extension: initial experience from a prospective single-arm study

Efficacy endpoints

VARTD (n = 21)

Primary efficacy endpoints

Reduction in size of necrotic collection after VARTD, n (%)

 ≥ 75% reduction in any axis

14 (67)

 ≥ 75% reduction in transverse axis

13 (62)

 ≥ 50% reduction in transverse axis

19 (90)

 ≥ 75% reduction in AP axis

9 (43)

 ≥ 50% reduction in AP axis

16 (76)

 Clinical resolution of sepsis or organ dysfunction, n (%)

21 (100)

Secondary efficacy endpoint

 Repeated interventions for additional drainage/debridement, n (%)

0

  1. VARTD, video-assisted retroperitoneal and/or transperitoneal debridement; AP, anteroposterior